Abstract
Using effector analysis, we studied the mechanism of anti-seizure activity of the alcoxy-derived benzodiazepine (propoxazepam). In models of chemically induced seizures we determined the average molar and weight effective doses (ED50) of propoxazepam as an antagonist of picrotoxin (4.10 ± 0.21 μmol/kg, 1.67 ± 0.09 mg/kg), pentylenetetrazole (2.24 ± 0.93 μmol/kg, 0.9 ± 0.04 mg/kg), and strychnine (40.33 ± 14.91 μmol/kg, 14.24 ± 0.47 mg/kg), which reflect the high activity level of the substance. On the basis of dose–effect curves, using comparative quantile analysis for chemoconvulsants with different mechanisms of action, we showed different stages of interaction of propoxazepam with GABA and glycine receptors under in vivo conditions. We evaluated the partial contribution of myoclonic and toxic components to the general structure of seizures induced by various chemoconvulsants. We believe that the results we obtained indicate that the anti-seizure action of propoxazepam is predominantly mediated by a GABAergic mechanism. Glycinergic components of the inhibition of strychnine-induced seizures by propoxazepam occur at doses that exceed the ED50 and seem to be an additional means of anti-seizure action.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Pavlovsky, V.I., Tsymbalyuk, O.V., Martynyuk, V.S., Kabanova, T.A., Semenishyna, E.A., Khalimova, E.I., and Andronati, S.A., Neurophysiology, 2013, vol. 45, nos 5-6, pp. 427–432.
Golovenko, N.Ya., Larionov, V.B., and Reder, A.S., Voloshchuk N.I., Valivodz I.P., Taran I.V, Zhurn. Natsional’noi Akademii Meditsinskikh Nauk Ukrainy, 2016, no. 3, pp. 251–260.
Bryans, J.S. and Wustrow, D.J., Med. Res. Rev., 1999, vol. 19, pp. 149–177.
Pavlovskii, V.I., Kabanova, T.A., Khalimova, E.I., and Andronati, S.A., Vestnik Odesskogo Natsional’nogo Universiteta. Seriya “Khimiya”, 2013, vol. 18, no. 3, pp. 28–38.
Urbakh, V.Yu., in Statisticheskii analiz v biologicheskikh i meditsinskikh issledovaniyakh (Statistical Analysis in Medical Studies), Moscow: Meditsina, 1975.
Varden, B., in Matematicheskaya statistika (Mathematical Statistics), Moscow: Izd-vo Inostr. Lit, 1960.
Buchinsky, M., J. Human Resources, 1998, vol. 33, no. 1, pp. 88–126.
Koenker, R., Quantile Regression, University of Illinois, Urbana-Champaign, 2005, p. 368.
Imming, P., Sinning, C., and Meyer, A., Drug Discovery, 2006, vol. 5, pp. 821–834.
Amakhin, D.V. and Veselkin, N.P., Tsitologiya, 2012, no. 6, pp. 469–477.
Danilov, A.B. and Davydov, O.S., in Neiropaticheskaya bol’ (Neuropathic Pain), Moscow: Borges, 2007.
Jung, M.E. and Lai, H., Neurosci. Biobehav. Rev., 2002, vol. 26, no. 4, pp. P. 429–439.
Carlton, S.M., Zhou, S., and Coggeshall, R.E., Neuroscience, 1999, vol. 93, no. 2, pp. 713–722.
Ramanyaneyulu, R. and Ticku, M.K., Eur. J. Pharmacol., 1984, vol. 98, pp. 337–345.
Bloom, P., Madeja, M., Mushhoff, U., and Specmann, E.-J., Neurosci. Let., 1996, vol. 205, pp. 115–118.
Vauquelin, G., Van Liefde, I., and Vanderheyden, P., Trends in Pharmacological Sciences, 2002, vol. 23, no. 11, pp. 514–518.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © N.Ya. Golovenko, V.B. Larionov, A.S. Reder, I.P. Valivodz’, 2017, published in Neirokhimiya, 2017, Vol. 34, No. 4, pp. 303–309.
Rights and permissions
About this article
Cite this article
Golovenko, N.Y., Larionov, V.B., Reder, A.S. et al. An effector analysis of the interaction of propoxazepam with antagonists of GABA and glycine receptors. Neurochem. J. 11, 302–308 (2017). https://doi.org/10.1134/S1819712417040043
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712417040043